ITCC-059 INOTUZUMAB
T2015-001 A phase I study of Inotuzumab Ozogamycin as a single agent and in combination with chemotherapy for pediatric CD22-positive relapsed/refractory Acute Lymphoblastic Leukemia
Promotor Name : Erasmus/TACL
Investigator Name : Zwaan Michel
